FINANCIAL HIGHLIGHTS

A range of 22 P&G products across each of the Company’s 10 categories.

(Unaudited)
Amounts in billions, except per share amounts

Net Sales

20222021202020192018
$80.2$76.1$71.0$67.7$66.8

Operating Income

20222021202020192018
$17.8$18.0$15.7$5.5$13.4

Net Earnings Attributable to P&G

20222021202020192018
$14.7$14.3$13.0$3.9$9.8

Net Earnings Margin from Continuing Operations

20222021202020192018
18.4%18.9%18.5%5.9%14.8%

Diluted Net Earnings per Common Share from Continuing Operations 1

20222021202020192018
$5.81$5.50$4.96$1.43$3.67

Diluted Net Earnings per Common Share1 

20222021202020192018
$5.81$5.50$4.96$1.43$3.67

Core Earnings per Share2

20222021202020192018
$5.81$5.66$5.12$4.52$4.22

Operating Cash Flow

20222021202020192018
$16.7$18.4$17.4$15.2$14.9

Dividends per Common Share

20222021202020192018
$3.52$3.24$3.03$2.90$2.79

2022 NET SALES BY
BUSINESS SEGMENT
3

Fabric & Home Care

35%

Baby, Feminine & Family Care

25%

Beauty

18%

Health Care

14%

Grooming

8%

2022 NET SALES BY
GEOGRAPHIC REGION

North America4

49%

Europe

21%

Greater China

10%

Asia Pacific

8%

Latin America

6%

India, Middle East
& Africa (IMEA)

6%

(1) Diluted net earnings per common share are calculated based on net earnings attributable to Procter & Gamble.
(2) Core EPS is a measure of the Company’s diluted net earnings per common share from continuing operations adjusted for certain items not viewed as part of our sustainable results. Please see page 74 of the Annual Report for detail on the reconciling items.
(3) These results exclude net sales in Corporate.
(4) North America includes the United States, Canada and Puerto Rico.


Please see Measures Not Defined by U.S. GAAP in the Downloads section, or page 74 of the print Annual Report, for definitions of non-GAAP measures and reconciliations to the most closely related GAAP measure.

VARIOUS STATEMENTS IN THIS ANNUAL REPORT, including estimates, projections, objectives and expected results, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are generally identified by the words “believe,” “expect,” “anticipate,” “intend,” “opportunity,” “plan,” “project,” “will,” “should,” “could,” “would,” “likely” and similar expressions. Forward-looking statements are based on current assumptions that are subject to risks and uncertainties that may cause actual results to differ materially from the forward-looking statements, including the risks and uncertainties discussed in Item 1A – Risk Factors of the Form 10-K included in this Annual Report. Such forward-looking statements speak only as of the date they are made, and we undertake no obligation to update or revise publicly any forward-looking statements, except as required by law.

Brand names referenced in this Annual Report are trademarks of The Procter & Gamble Company or one of its subsidiaries. All other brand names are trademarks of their respective owners.